UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 84

Sortiert nach

Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value

Blood, 2010-11, Vol.116 (19), p.3923-3932

2010

Volltextzugriff (PDF)

Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

Journal of clinical oncology, 2010-01, Vol.28 (3), p.405-411

2010

Volltextzugriff (PDF)

Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab

Haematologica (Roma), 2009-07, Vol.94 (7), p.956-966

2009

Volltextzugriff (PDF)

Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia

Blood, 2011-08, Vol.118 (8), p.2351-2357

2011

Volltextzugriff (PDF)

IL‐17‐producing CD4+ T cells, pro‐inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome

British journal of haematology, 2009-04, Vol.145 (1), p.64-72

2009

Volltextzugriff (PDF)

Diffuse large B-cell lymphoma developing following treatment of Waldenstrom's macroglobulinaemia: Spontaneous resolution upon cessation of fludarabine

Leukemia & lymphoma, 2007-01, Vol.48 (8), p.1638-1640

2007

Volltextzugriff (PDF)

HLA-Haploidentical Hematopoietic Cell Transplantation after TCR-Αβ and CD45RA+ Depletion Following Reduced Intensity Conditioning in Adults and Children with Hematological Malignancies- Two-Year Follow-up of Multicenter Study in Singapore

Blood, 2019-11, Vol.134 (Supplement_1), p.2039-2039

2019

Volltextzugriff (PDF)

Disease Risk Index (DRI) and Conditioning Regimen Based Risk Stratification of Outcome Among Adults with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation

Biology of blood and marrow transplantation, 2016-03, Vol.22 (3), p.S364-S364

2016

Volltextzugriff (PDF)

Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients

Expert review of anti-infective therapy, 2011-10, Vol.9 (10), p.891-899

2011

Volltextzugriff (PDF)

Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapy

British journal of haematology, 2007-05, Vol.137 (4), p.374-375

2007

Volltextzugriff (PDF)

Double Unit Umbilical Cord Blood Transplant for Adults with Acute Leukemia and Myelodysplastic Syndrome Results in Comparable Outcome As Matched Sibling or Unrelated Donor Transplant Only after Myeloablative Conditioning but Not Reduced Intensity Conditio

Biology of blood and marrow transplantation, 2014-02, Vol.20 (2), p.S247-S247

2014

Volltextzugriff (PDF)

Allogeneic Stem Cell Transplantation for Accelerated/Blastic Phase Philadelphia-Chromosome Negative MPN

Blood, 2012-11, Vol.120 (21), p.4532-4532

2012

Volltextzugriff (PDF)

Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab

British journal of haematology, 2010-06, Vol.149 (6), p.879-889

2010

Volltextzugriff (PDF)

Telomere Length In MDS Patients Bone Marrow Is Highly Correlated with Complex Cytogenetics, IPSS Risk Groups and Transfusion Dependency

Blood, 2011-11, Vol.118 (21), p.3826-3826

2011

Volltextzugriff (PDF)

Pre-Emptive Donor Lymphocyte Infusions (DLI) Lead to High Cure Rates in T-Cell Depleted Allogeneic Haemopoietic Stem Cell Transplants for MDS/AML

Blood, 2011-11, Vol.118 (21), p.660-660

2011

Volltextzugriff (PDF)

National, Retrospective, Multi-Centre Comparison of Alemtuzumab- Versus ATG-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation for Aplastic Anemia: A Study From the British Society for Blood and Marrow Transplantation (BSBMT) (CTCR 09-03)

Blood, 2011-11, Vol.118 (21), p.52-52

2011

Volltextzugriff (PDF)

TP53 Mutations Are Restricted Predominantly to 5q- Syndrome and Myelodysplastic Syndrome Patients with Complex Cytogenetics, and Correlate with Adverse Prognosis

Blood, 2011-11, Vol.118 (21), p.792-792

2011

Volltextzugriff (PDF)

Long-Term Outcomes of Reduced Intensity Conditioning Haematopoietic Stem Cell Transplantation (RIC-HSCT) for AML with Myelodysplasia-Related Changes

Blood, 2011-11, Vol.118 (21), p.3079-3079

2011

Volltextzugriff (PDF)

Contrasting Roles of Th1 and Th17 Cells in Aplastic Anaemia (AA) and Myelodysplastic Syndrome (MDS)

Blood, 2009-11, Vol.114 (22), p.1090-1090

2009

Volltextzugriff (PDF)

A Decade of Reduced-Intensity Conditioned Allogeneic Haematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes Following Conditioning with Fludarabine, Busulphan and Alemtuzumab

Blood, 2009-11, Vol.114 (22), p.2266-2266

2009

Volltextzugriff (PDF)

Alemtuzumab Used with Fludarabine and Cyclophosphamide (FCC) for Stem Cell Transplantation in Acquired Aplastic Anemia Is Associated with a Low Risk of Graft Versus Host Disease and Viral Infections and with Sustained Engraftment

Blood, 2009-11, Vol.114 (22), p.1084-1084

2009

Volltextzugriff (PDF)

Successful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone

Haematologica (Roma), 2006-08, Vol.91 (8 Suppl), p.ECR44-ECR44

2006

Volltextzugriff (PDF)

Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data

British journal of haematology, 2007-02, Vol.136 (3), p.448-450

2007

Volltextzugriff (PDF)

Comparative Analysis of An Azacytidine Versus Azacytidine-HSCT Approach for the Treatment of Older Patients with AML/MDS

Blood, 2010-11, Vol.116 (21), p.2375-2375

2010

Volltextzugriff (PDF)

Alemtuzumab-Based RIC HSCT with Pre-Emptive DLI as An Effective Strategy to Achieve Long-Term Disease Remission In Patients with High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML)

Blood, 2010-11, Vol.116 (21), p.1304-1304

2010

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(83)
Tagungsberichte
(1)

Sprache

Englisch
(84)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(25)
Humans
(23)
Male
(16)
Hematology
(15)
Female
(14)
Adult
(13)
Middle Aged
(12)
Aged
(10)
Biological And Medical Sciences
(8)
Hematologic And Hematopoietic Diseases
(8)
Medical Sciences
(8)
Alemtuzumab
(6)
Chemistry
(6)
Oncology
(6)
Physical Sciences
(6)
Transplantation, Homologous
(6)
Treatment Outcome
(6)
Antibodies, Monoclonal, Humanized
(5)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value

Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab

Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia

IL‐17‐producing CD4+ T cells, pro‐inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome

Diffuse large B-cell lymphoma developing following treatment of Waldenstrom's macroglobulinaemia: Spontaneous resolution upon cessation of fludarabine

HLA-Haploidentical Hematopoietic Cell Transplantation after TCR-Αβ and CD45RA+ Depletion Following Reduced Intensity Conditioning in Adults and Children with Hematological Malignancies- Two-Year Follow-up of Multicenter Study in Singapore

Disease Risk Index (DRI) and Conditioning Regimen Based Risk Stratification of Outcome Among Adults with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation

Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients

Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapy

Double Unit Umbilical Cord Blood Transplant for Adults with Acute Leukemia and Myelodysplastic Syndrome Results in Comparable Outcome As Matched Sibling or Unrelated Donor Transplant Only after Myeloablative Conditioning but Not Reduced Intensity Conditio

Allogeneic Stem Cell Transplantation for Accelerated/Blastic Phase Philadelphia-Chromosome Negative MPN

Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab

Telomere Length In MDS Patients Bone Marrow Is Highly Correlated with Complex Cytogenetics, IPSS Risk Groups and Transfusion Dependency

Pre-Emptive Donor Lymphocyte Infusions (DLI) Lead to High Cure Rates in T-Cell Depleted Allogeneic Haemopoietic Stem Cell Transplants for MDS/AML

National, Retrospective, Multi-Centre Comparison of Alemtuzumab- Versus ATG-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation for Aplastic Anemia: A Study From the British Society for Blood and Marrow Transplantation (BSBMT) (CTCR 09-03)

TP53 Mutations Are Restricted Predominantly to 5q- Syndrome and Myelodysplastic Syndrome Patients with Complex Cytogenetics, and Correlate with Adverse Prognosis

Long-Term Outcomes of Reduced Intensity Conditioning Haematopoietic Stem Cell Transplantation (RIC-HSCT) for AML with Myelodysplasia-Related Changes

Contrasting Roles of Th1 and Th17 Cells in Aplastic Anaemia (AA) and Myelodysplastic Syndrome (MDS)

A Decade of Reduced-Intensity Conditioned Allogeneic Haematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes Following Conditioning with Fludarabine, Busulphan and Alemtuzumab

Alemtuzumab Used with Fludarabine and Cyclophosphamide (FCC) for Stem Cell Transplantation in Acquired Aplastic Anemia Is Associated with a Low Risk of Graft Versus Host Disease and Viral Infections and with Sustained Engraftment

Successful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone

Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data

Comparative Analysis of An Azacytidine Versus Azacytidine-HSCT Approach for the Treatment of Older Patients with AML/MDS

Alemtuzumab-Based RIC HSCT with Pre-Emptive DLI as An Effective Strategy to Achieve Long-Term Disease Remission In Patients with High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML)

Suchergebnisse filtern